HR7189-118 · 118th Congress
Signed into Law
Signed Nov 21, 2024Congenital Heart Futures Reauthorization Act of 2024
Congenital Heart Futures Reauthorization Act of 2024 This bill reauthorizes through FY2029 the National Congenital Heart Disease Research, Surveillance, and Awareness Program, which is administered by the Centers for Disease Control and Prevention. The program supports data collection, educational campaigns, and other efforts to better understand the causes and effects of congenital heart disease across various demographics.
VOTE BREAKDOWN
No recorded floor vote
Most bills never receive a recorded roll-call vote — they're referred to committee and don't advance to the floor. The sponsor and funding context on this page still tells you who is behind it and what industries have a stake.
SPONSORS
Gus M. Bilirakis
R-FL · Primary
4 COSPONSORS
BIPARTISAN● 2 D● 2 R
SPONSOR FUNDING
Top industries funding Bilirakis
Health Services23%
Single-Issue Advocacy11%
Pharmaceuticals & Biotech10%
Telecommunications8%
Retail & Consumer7%
TRAIL AI
The Congenial Heart Futures Reauthorization Act of 2024 (HR 7189) reauthorizes federal programs and initiatives related to congenital heart disease research, education, and patient support. The bill was introduced by Representative Gus M. Bilirakis (R-FL) and has been signed into law. Voting data for this legislation is not yet available.
Based on public voting records. Does not imply causation.
TIMELINE
INTRODUCEDFeb 1, 2024
PASSED SENATESep 25, 2024
SIGNEDNov 21, 2024
DATA SOURCES
Bill data: Congress.gov · 117th–119th Congress (2021–present)
Vote records: House Clerk / Senate · 2021–present
Reflects public records. Does not imply causation.
